Market Cap 2.54B
Revenue (ttm) 874.84M
Net Income (ttm) 263.86M
EPS (ttm) N/A
PE Ratio 6.72
Forward PE N/A
Profit Margin 30.16%
Debt to Equity Ratio -1.85
Volume 2,122,100
Avg Vol 4,712,944
Day's Range N/A - N/A
Shares Out 255.54M
Stochastic %K 42%
Beta 0.56
Analysts Strong Sell
Price Target $20.55

Company Profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat HAE. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 859 1302
Fax: 919 859 1314
Address:
4505 Emperor Boulevard, Suite 200, Durham, United States
Valueforall
Valueforall Aug. 19 at 2:01 PM
$BCRX adios
0 · Reply
Valueforall
Valueforall Aug. 19 at 1:58 PM
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:48 PM
$BCRX Mortgage applications fell by 0.4% in the week ended Aug. 14, with an increase in refinancing activity offset by a decline in home purchase applications, according to Mortgage Bankers Association data released Wednesday.
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:47 PM
$BCRX The minutes from the most recent Federal Open Market Committee meeting will be released at 2 pm ET.
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:43 PM
$BCRX France Just Kicked Microsoft Off 2.5 Million Government Devices – Here’s Why Add Yahoo as a preferred source to see more of Add Yahoo as a preferred source to see more of European governments are shifting away from Microsoft Windows and U.S. tech stacks toward Linux and open-source alternatives to achieve digital sovereignty, reduce foreign vendor lock-in, and bypass foreign data surveillance laws like the U.S. Cloud Act. High-profile migrations include France's national transition strategy, Germany's Schleswig-Holstein state moving 30,000 PCs, and similar moves in Denmark. https://www.yahoo.com/news/articles/france-just-kicked-microsoft-off-161724952.html
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:32 PM
$BCRX Big spreads again today Biocryst Pharmaceuticals price per share$9.93 +$0.23 (2.37%) Bid XNMS 9.88 x 200 Ask XNMS 9.96 x 800 Volume 46,320
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:26 PM
$BCRX https://finance.yahoo.com/markets/stocks/articles/moderna-shares-soar-60-on-melanoma-vaccine-trial-success-113706098.html
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:25 PM
$BCRX NasdaqGS - Delayed Quote • USD Moderna, Inc. (MRNA) 62.96 -1.50 (-2.33%) At close: August 18 at 4:00:01 PM EDT 118.10 +55.14 (+87.58%)
0 · Reply
Fergus20
Fergus20 Aug. 19 at 12:32 PM
$BCRX please be our day
1 · Reply
Fergus20
Fergus20 Aug. 19 at 12:09 PM
$BCRX now that cancer is cured can we focus on BCRX?
1 · Reply
Latest News on BCRX
BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 14 days ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2026


BioCryst Pharmaceuticals Earnings release: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 14 days ago

BioCryst Pharmaceuticals Earnings release: Q2 2026


BioCryst Pharmaceuticals Slides: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 14 days ago

BioCryst Pharmaceuticals Slides: Q2 2026


BioCryst Pharmaceuticals Quarterly report: Q2 2026

Aug 5, 2026, 8:30 AM EDT - 14 days ago

BioCryst Pharmaceuticals Quarterly report: Q2 2026


BioCryst Reports Second Quarter 2026 Financial Results

Aug 5, 2026, 7:00 AM EDT - 14 days ago

BioCryst Reports Second Quarter 2026 Financial Results


BioCryst Appoints David W. Jenkins as Chief Scientific Officer

Jul 15, 2026, 7:00 AM EDT - 5 weeks ago

BioCryst Appoints David W. Jenkins as Chief Scientific Officer


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2026


BioCryst Pharmaceuticals Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

BioCryst Pharmaceuticals Earnings release: Q1 2026


BioCryst Pharmaceuticals Slides: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

BioCryst Pharmaceuticals Slides: Q1 2026


BioCryst Pharmaceuticals Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

BioCryst Pharmaceuticals Quarterly report: Q1 2026


BioCryst to Present at Upcoming Investor Conferences

Apr 28, 2026, 7:00 AM EDT - 4 months ago

BioCryst to Present at Upcoming Investor Conferences


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst Pharmaceuticals Proxy statement: Proxy filing

Apr 23, 2026, 8:00 AM EDT - 4 months ago

BioCryst Pharmaceuticals Proxy statement: Proxy filing


BioCryst to Report First Quarter 2026 Financial Results on May 6

Apr 15, 2026, 7:00 AM EDT - 4 months ago

BioCryst to Report First Quarter 2026 Financial Results on May 6


BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025


BioCryst Pharmaceuticals Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Annual report: Q4 2025


BioCryst Pharmaceuticals Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Earnings release: Q4 2025


BioCryst Pharmaceuticals Slides: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

BioCryst Pharmaceuticals Slides: Q4 2025


BioCryst to Present at Upcoming Investor Conference

Feb 17, 2026, 7:00 AM EST - 6 months ago

BioCryst to Present at Upcoming Investor Conference


BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q3 2025


BioCryst Pharmaceuticals Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Quarterly report: Q3 2025


BioCryst Pharmaceuticals Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Earnings release: Q3 2025


BioCryst Pharmaceuticals Slides: Q3 2025

Nov 3, 2025, 8:30 AM EST - 10 months ago

BioCryst Pharmaceuticals Slides: Q3 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 11 months ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 11 months ago

BioCryst Pharmaceuticals Press release: M&A Announcement


BioCryst Pharmaceuticals Slides: M&A Announcement

Oct 14, 2025, 8:00 AM EDT - 11 months ago

BioCryst Pharmaceuticals Slides: M&A Announcement


BioCryst to buy Astria Therapeutics in $700 million deal

Oct 14, 2025, 7:35 AM EDT - 11 months ago

BioCryst to buy Astria Therapeutics in $700 million deal

ATXS


BioCryst Announces Departure of Dr. Helen Thackray

Aug 11, 2025, 7:00 AM EDT - 1 year ago

BioCryst Announces Departure of Dr. Helen Thackray


BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q2 2025


BioCryst Pharmaceuticals Quarterly report: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Quarterly report: Q2 2025


BioCryst Pharmaceuticals Earnings release: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q2 2025


BioCryst Pharmaceuticals Slides: Q2 2025

Aug 4, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Slides: Q2 2025


BioCryst Pharmaceuticals Transcript: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Transcript: M&A Announcement


BioCryst Pharmaceuticals Press release: M&A Announcement

Jun 27, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Press release: M&A Announcement


ORLADEYO® (berotralstat) Approved in Colombia

Jun 13, 2025, 7:00 AM EDT - 1 year ago

ORLADEYO® (berotralstat) Approved in Colombia


BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings Call Transcript: Q1 2025


BioCryst Pharmaceuticals Quarterly report: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Quarterly report: Q1 2025


BioCryst Pharmaceuticals Earnings release: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Earnings release: Q1 2025


BioCryst Pharmaceuticals Slides: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

BioCryst Pharmaceuticals Slides: Q1 2025


BioCryst Appoints Steve Frank to Board of Directors

May 1, 2025, 7:00 AM EDT - 1 year ago

BioCryst Appoints Steve Frank to Board of Directors


BioCryst Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

BioCryst Pharmaceuticals Proxy statement: Proxy Filing


BioCryst Pharmaceuticals Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

BioCryst Pharmaceuticals Proxy statement: Proxy Filing


Valueforall
Valueforall Aug. 19 at 2:01 PM
$BCRX adios
0 · Reply
Valueforall
Valueforall Aug. 19 at 1:58 PM
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:48 PM
$BCRX Mortgage applications fell by 0.4% in the week ended Aug. 14, with an increase in refinancing activity offset by a decline in home purchase applications, according to Mortgage Bankers Association data released Wednesday.
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:47 PM
$BCRX The minutes from the most recent Federal Open Market Committee meeting will be released at 2 pm ET.
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:43 PM
$BCRX France Just Kicked Microsoft Off 2.5 Million Government Devices – Here’s Why Add Yahoo as a preferred source to see more of Add Yahoo as a preferred source to see more of European governments are shifting away from Microsoft Windows and U.S. tech stacks toward Linux and open-source alternatives to achieve digital sovereignty, reduce foreign vendor lock-in, and bypass foreign data surveillance laws like the U.S. Cloud Act. High-profile migrations include France's national transition strategy, Germany's Schleswig-Holstein state moving 30,000 PCs, and similar moves in Denmark. https://www.yahoo.com/news/articles/france-just-kicked-microsoft-off-161724952.html
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:32 PM
$BCRX Big spreads again today Biocryst Pharmaceuticals price per share$9.93 +$0.23 (2.37%) Bid XNMS 9.88 x 200 Ask XNMS 9.96 x 800 Volume 46,320
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:26 PM
$BCRX https://finance.yahoo.com/markets/stocks/articles/moderna-shares-soar-60-on-melanoma-vaccine-trial-success-113706098.html
0 · Reply
Paulzk
Paulzk Aug. 19 at 1:25 PM
$BCRX NasdaqGS - Delayed Quote • USD Moderna, Inc. (MRNA) 62.96 -1.50 (-2.33%) At close: August 18 at 4:00:01 PM EDT 118.10 +55.14 (+87.58%)
0 · Reply
Fergus20
Fergus20 Aug. 19 at 12:32 PM
$BCRX please be our day
1 · Reply
Fergus20
Fergus20 Aug. 19 at 12:09 PM
$BCRX now that cancer is cured can we focus on BCRX?
1 · Reply
Paulzk
Paulzk Aug. 19 at 11:25 AM
$BCRX Rising long-term rates, he argued, can function the same way, gradually "letting air out of the stock market" even without a formal Fed tightening cycle.
0 · Reply
Paulzk
Paulzk Aug. 19 at 11:24 AM
$BCRX He said he believes commodity markets are similarly mispricing risk: crude oil inventories are running toward the bottom of the barrel, in his view, setting up oil prices to "come roaring back" within the next month or two,
0 · Reply
Paulzk
Paulzk Aug. 19 at 11:22 AM
$BCRX he argued that inflation expectations—not just realized inflation—are what drive bond yields, and those expectations are being fed by faster money growth. "The inflation genie's out of the bottle, and it's not going back in," he said. Divisia M4—the broadest and, in his view, most reliable measure of the money supply, produced by the Center for Financial Stability and tracked by monetary economist William Barnett. This is growing at 6.7% year-over-year https://finance.yahoo.com/economy/policy/articles/top-economist-trump-deadly-cocktail-070000763.html
0 · Reply
Paulzk
Paulzk Aug. 19 at 11:12 AM
$BCRX Global food prices are expected to increase by 11.8% this year and by 4.8% in 2027, with the most severe impact expected to be on crops — grains, fruit and vegetables — and dairy, according to Oxford Economics. This comes as Europe's extreme heat and drought have damaged crops, while farmers are also facing high energy and fertiliser prices, compounded by the wars in the Middle East and Ukraine. https://finance.yahoo.com/markets/commodities/articles/war-heatwaves-threaten-push-bread-050107526.html
0 · Reply
Paulzk
Paulzk Aug. 19 at 11:08 AM
$BCRX Does Trump have a clue that if you insult, alienate and attack countries with high tariffs you can't expect them to show up at your Treasury auctions. The discount the US gets for being a reserve currency is disappearing quickly.
0 · Reply
Fergus20
Fergus20 Aug. 19 at 11:04 AM
$MRNA $BCRX is better
0 · Reply
Paulzk
Paulzk Aug. 19 at 11:04 AM
$BCRX A aggressive global bond sell-off has driven government borrowing costs to multiyear highs. A primary catalyst is the expiration of a U.S.-Iran truce, which renewed fears of inflation and protracted high oil prices due to threats surrounding the critical Strait of Hormuz. Global bond markets are getting hammered. Here’s why that could make your life more expensive And it wasn’t just US bonds. In France and Germany, 10-year bond yields this week hit their highest levels since 2008 and 2011, respectively. In Japan, the 10-year yield hit its highest level in 30 years. https://www.forbes.com/sites/brandonkochkodin/2026/08/18/why-the-safest-bonds-are-performing-dismally-compared-to-junk-debt/
0 · Reply
Paulzk
Paulzk Aug. 19 at 10:59 AM
$BCRX Meanwhile, organizations that are supposed to be independent like the FBI and the FCC, our radio and television regulator, have also been targeting press freedom under Trump-aligned leadership
1 · Reply
Paulzk
Paulzk Aug. 19 at 10:57 AM
$BCRX North Korea has deepened military ties with Russia since they signed a comprehensive strategic partnership pact in June 2024. Pyongyang is providing troops, artillery ammunition and ballistic missiles to support Moscow’s war against Ukraine.
0 · Reply
Paulzk
Paulzk Aug. 19 at 10:54 AM
$BCRX Trump is making the US a pariah. 'citing warm ties with Kim Jong-un' That's just retarded. South Korea president calls for military independence in wake of Trump call to cut joint drills Lee Jae Myung reiterates desire for full command back in Seoul’s hands after Donald Trump cuts joint exercises, citing warm ties with Kim Jong-un ‘Inane, haphazard decision’ by Trump to gut South Korea alliance https://www.theguardian.com/world/2026/aug/18/south-korea-president-trump-military-drills-control-opcon-kim-jong-un
0 · Reply
Paulzk
Paulzk Aug. 19 at 10:47 AM
$BCRX Iran, declaring the strait under its control, has attacked dozens of ships that tried to to travel the waterway via the north coast of Oman. Despite the risk, most ships have recently chosen to ignore Iran’s demands and cross the strait with the promise of protection from US naval forces. “It increasingly looks like Iran has at least partially lost control of the strait,” said Homayoun Falakshahi, head of crude oil analysis at Kpler. https://www.cnn.com/2026/08/18/business/iran-strait-of-hormuz-oil
0 · Reply
Valueforall
Valueforall Aug. 18 at 7:50 PM
$BCRX I feel for @Fergus20 so gonna share some light hearted stuff $WVE I had this cool pal at a previous company named Nitin a total tech geek turned trader. He was an introverted, quiet nerd and a gentle soul. Soft-spoken and kept his head down, you’d never expect him to make a scene. However, there was something about buying good stocks cheap and beaten down that would bring out this wild and crazy side in him. When he bought a stock he felt was murdered for no good reason, the quiet tech guy vanished. He would put Panjabi MC on the speakers, jump out of his chair, and start full-on dancing and singing right on the floor with both his pointer fingers dangling in the air. ‘While some mudderphuckers are buying the dip, other mudderphuckers are sucking their (you know what)’ It was hilarious 😂. He passed away due to cancer but was able to leave his loved one and little daughter a nice cushion to live off of. I miss him. This moment reminds me of that
1 · Reply